Feb 4, 2017
[x]
commission for @kerx
commission info
seen from India
seen from United States
seen from Türkiye
seen from China
seen from Taiwan
seen from Singapore
seen from United Kingdom
seen from Malaysia
seen from United States
seen from Malaysia
seen from Malaysia
seen from China
seen from United States
seen from Canada
seen from United States
seen from United States
seen from Russia
seen from India
seen from Türkiye
seen from Netherlands
[x]
commission for @kerx
commission info
I commissioned the wonderful @kerx to do my wonderful Tiefling Druid Lerissa and I am IN LOVE!!
Look at her <3
H O L D T H E L I N E
HOLD
THE
LINE
Me: You think I should do this?
Friend: You're gonna do it anyway, no matter what we say.
Me: You're right.
(Nasdaq:KERX) Keryx Biopharmaceuticals Dips To New 52 Week Low
(Nasdaq:KERX) Keryx Biopharmaceuticals Dips To New 52 Week Low
Keryx Biopharmaceuticals (Nasdaq:KERX)
September 13th, 2018
Amidst rising markets Keryx Biopharmaceuticals finished Thursday’s trading session down 4.01%, a $0.12 decrease to close on $2.87. As well as the drop in value, Keryx Biopharmaceuticals hit a new 52 week low of $2.86, breaking the previous low of $2.93 from earlier this May. (more…)
View On WordPress
$KERX 2018-08-17 : Transcripts- Edited Transcript of KERX earnings conference call
$KERX 2018-08-17 : Transcripts- Edited Transcript of KERX earnings conference call
[s2If !current_user_can(access_s2member_level0)] Please login to read the transcript. [lwa] [/s2If][s2If current_user_can(access_s2member_level0)]”
Q2 2018 Keryx Biopharmaceuticals Inc Earnings Call
New York Aug 18, 2018 (Thomson StreetEvents) — Edited Transcript of Keryx Biopharmaceuticals Inc earnings conference call or presentation Wednesday, August 8, 2018 at 12:00:00pm GMT
TEXT version…
View On WordPress
Keryx Biopharmaceuticals (Nasdaq:KERX) Analysts Are Optimistic
Keryx Biopharmaceuticals (Nasdaq:KERX) Analysts Are Optimistic
Keryx Biopharmaceuticals (Nasdaq:KERX)
August 16th, 2018
Amidst rising markets Keryx Biopharmaceuticals finished Thursday’s trading session down 0.66%, a $0.02 decrease to close on $3.02. Be aware that the Altman Z-Score1 (An indicator of the probability for a 2-year bankruptcy) is below the recommended threshold of 1.8%, and calculated to be -10.76. (more…)
View On WordPress
Breaking The Old 52 Week Low, Keryx Biopharmaceuticals (Nasdaq:KERX) Closing At $3.13
Breaking The Old 52 Week Low, Keryx Biopharmaceuticals (Nasdaq:KERX) Closing At $3.13
Keryx Biopharmaceuticals (Nasdaq:KERX)
August 13th, 2018
Amidst falling markets Keryx Biopharmaceuticals finished Monday’s trading session down 4.57%, a $0.15 decrease to close on $3.13. As well as the drop in value, Keryx Biopharmaceuticals hit a new 52 week low of $3.04, breaking the previous low of $3.27 from earlier this month. (more…)
View On WordPress